Stock listing

TSX:NVLN Novelion Therapeutics Inc Stock

Follow Novelion Therapeutics Inc into a list and get an email when it puts out news.

Delisted TSX:NVLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
TSX:NVLN
Asset type
Stock
Exchange
TSX
Currency
CAD

Where Novelion Therapeutics Inc is listed

ListingExchangeCountryCurrency
TSX:NVLN · This page · DelistedTSXCanadaCAD
NASDAQ:NVLN · DelistedNASDAQUnited StatesUSD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Suzanne L. Bruhn
Other companies: Definium Therapeutics, Inc. (Director · Since at least Aug 11, 2022); Vigil Neuroscience Inc (Director · Since at least Jul 27, 2022); Pliant Therapeutics, Inc. (Director · Since at least Jun 2, 2020); Travere Therapeutics, Inc. (Director · Since at least Apr 8, 2020); Avalo Therapeutics, Inc. (Director · Apr 24, 2020 – Nov 10, 2021 · Past); Spyre Therapeutics, Inc. (Director · Feb 15, 2017 – Jun 8, 2020 · Past); Raptor Pharmaceutical Corp (Director · Sep 25, 2012 – Oct 24, 2016 · Past)
Director · Oct 1, 2017 – Aug 9, 2018 · Past
Jorge MD Plutzky
Other companies: Aegerion Pharmaceuticals Inc (Director · Nov 29, 2016 – Nov 29, 2016 · Past); VIVUS Inc (Director · Apr 29, 2016 – Feb 20, 2020 · Past)
Director · Nov 29, 2016 – Dec 22, 2016 · Past
Dipak PanigrahiSVP, R&D and CMO · Apr 29, 2010 – May 21, 2010 · Past
Roger LouisSee Remarks · May 9, 2019 – May 9, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Novelion Therapeutics Inc.